Candice French is a purpose-driven leader with a high attention to detail and strong communication skills. With nearly 14 years of industry experience, she has worked on all phases of clinical trials in various positions including Project Manager, Clinical Team Lead and Clinical Research Associate. Over the course of her career, she has successfully led trials of varying size and complexity, both domestically and internationally.

Ms. French has experience in numerous therapeutic areas but the majority of her career has been focused on CNS indications, including  major depressive disorder, panic disorder, schizoaffective disorder, and neurological disease, including Alzheimer’s disease. She is accomplished in operationalizing a variety of complex cognitive and neuropsychological assessments, including many specialty procedures.

Ms. French is accustomed to overcoming the unique challenges of these complex psychiatric and neurological indications, with a strong focus on minimizing placebo response and patient retention and compliance. She possesses in-depth experience with Phase I trials, including healthy volunteer, in-patient, specialty populations, and drug interaction studies.

Ms. French received her BS in Psychology from The University of Arizona.

Why Clinical Research?

“I happened upon an ad for a CRA internship out of college and though I had very little knowledge of the industry, I was charmed by the prospect of making a living wage while travelling. I quickly fell in love with clinical research, specifically captivated by the opportunity to continuously learn about a variety of diseases and drugs. The ever-changing landscape of clinical research perfectly fulfills my desire for continuing learning and change, with each client, indication, and protocol presenting unique challenges to overcome.”

This is what drives Candice:

“The human mind has always fascinated me and drove me to major in Psychology in college. I am especially intrigued by CNS trials and the various assessments that give us a glimpse into the patients’ most inner thoughts, their sense of self. I have seen firsthand how devastating many of the diseases that affect those inner workings can be, and I am passionate about expanding access to mental healthcare and bringing new therapies to improve these patients’ lives.”